European Management of Hyperglycemia in VLBW Infants - A Cross Sectional Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00039910

Enrollment

250

Registered

2026-04-15

Start date

2026-03-24

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperglycemia in VLBW Infants

Interventions

Group 1: Clinically practicing neonatologists from European neonatal units will complete an anonymous online questionnaire on their management of hyperglycemia in preterm infants <1500 g. No intervent

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Neonatologists in Europe

Exclusion criteria

Exclusion criteria: All individuals who are not clinically active neonatologists practicing in Europe are ineligible to participate.

Design outcomes

Primary

Measure	Time frame
Clinical practices in the management of hyperglycemia in very low birth weight preterm infants (<1500 g) will be assessed using an online questionnaire administered via the SurveyMonkey platform. The survey will capture the incidence of hyperglycemia in the neonatal intensive care unit, the commonly accepted definition of hyperglycemia, therapeutic threshold values and target ranges, as well as preferred treatment strategies, including their indications, methods of administration, and dosing.	—

Measure

Time frame

Clinical practices in the management of hyperglycemia in very low birth weight preterm infants (<1500 g) will be assessed using an online questionnaire administered via the SurveyMonkey platform. The survey will capture the incidence of hyperglycemia in the neonatal intensive care unit, the commonly accepted definition of hyperglycemia, therapeutic threshold values and target ranges, as well as preferred treatment strategies, including their indications, methods of administration, and dosing.

—

Countries

Austria, Belgium, Bulgaria, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland

Contacts

Public ContactLena Wiedenhaus

Universität Bielefeld

lena.wiedenhaus@uni-bielefeld.dekeine Angabe

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026